1 Min Read
Oct 30 (Reuters) - Novaliq:
* Novaliq’s NovaTears® treatment for evaporative dry eye disease launches in New Zealand and receives registrational approval in Australia Source text for Eikon:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.